SCHEMBL15465845

SCHEMBL15465845

COC(=O)c1sc2ccc(OCc3ccccc3)cc2c1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 1/20 0.59
DYRK1A Q13627 1/20 0.48
MAPT P10636 4/20 0.46
MAOB P27338 3/20 0.45
MAOA P21397 1/20 0.45
LMNA P02545 3/20 0.45
HPGD P15428 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MAPK1 P28482 1/20 0.45
ALDH1A1 P00352 4/20 0.45
SENP5 Q96HI0 1/20 0.45
SENP2 Q9HC62 1/20 0.45
SENP1 Q9P0U3 1/20 0.45
KDM4E B2RXH2 2/20 0.44
GAA P10253 2/20 0.44
SCD O00767 1/20 0.44
THRB P10828 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9372198 0.88 EDNRA (0.61) EDNRADYRK1AMAPTMAOBMAOA
SCHEMBL8021621 0.87 HPGD (0.48) EDNRAMAPTLMNAHPGDSMN1; SMN2
SCHEMBL9433720 0.87 EDNRA (0.60) EDNRADYRK1AMAOBMAOAMAPK1
SCHEMBL5230453 0.84 MAPT (0.55) MAPTLMNAHPGDNPC1RAB9A
SCHEMBL6656891 0.82 MAPK1 (0.58) DYRK1AMAPTLMNAHPGDNPC1
SCHEMBL9920609 0.81 MAPT (0.48) MAPTMAOBMAOALMNAHPGD
SCHEMBL1608173 0.81 STING1 (0.54) DYRK1AMAPTLMNAHPGDNPC1
SCHEMBL1609241 0.81 STING1 (0.54) DYRK1AMAPTLMNAHPGDNPC1
SCHEMBL8021187 0.81 DYRK1A (0.53) EDNRADYRK1AMAPTMAOBMAOA
SCHEMBL8024350 0.79 HPGD (0.55) DYRK1AMAPTLMNAHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9840515-B2 Protein kinase D inhibitors University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2017-12-12 US disclosed
US-9840515-B2 Protein kinase D inhibitors University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2017-12-12 US disclosed
US-20140045821-A1 PROTEIN KINASE D INHIBITORS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045821-A1 PROTEIN KINASE D INHIBITORS PRKCD, PRKD1, PRKD2 EDNRA 2113/4885DYRK1A 597/4885MAPT 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.